Overview
Investors searching USDD vs INJ usually want a clear market-cap and momentum snapshot. USDD prints $1,867.53 (+0.00%) while Injective is at $5.00 (+1.77%), with volume edge currently on Injective.
Quick winners
Full comparison
| Metric | USDD | INJ |
|---|---|---|
| Price | $1,867.53 | $5.00 |
| Market Cap | $1.59B | $490.41M |
| FDV | — | — |
| Volume 24h | $1.64M | $2.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 48.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USDD | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.00% | +1.77% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USDD | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 65.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on USDD and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | USDD | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USDD
Injective
Pros and cons
Pros of USDD
- Higher ranking for USDD can translate into tighter spreads on major venues.
- Composite PEPS readings for USDD can surface clearer module agreement during trend phases.
- Market-cap scale on USDD may dampen some idiosyncratic shocks versus smaller peers.
Cons of USDD
- Large-cap status for USDD can mean slower percentage upside versus high-beta alternatives.
- Regulatory or macro headlines can hit USDD harder simply because it is more visible.
- Crowded positioning around USDD sometimes amplifies squeeze or flush risk.
Pros of Injective
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Diversifying versus USDD with Injective can change portfolio factor exposure.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
In about three hundred words of context: USDD (USDD) trades near $1,867.53 with a +0.00% day move, while Injective (INJ) is around $5.00 (+1.77%). Volume leadership currently sits with Injective, and market-cap leadership with USDD. Technical trend labels read bearish vs neutral, with RSI near 49.02/49.29. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, USDD or Injective?
“Better” depends on horizon and risk. USDD leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USDD or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USDD and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.